SARAH CARVER: Open Payments
NPI 1356913271 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 79 payments from 15 companies in 2025. Trend: 2023 $35 · 2024 $544 · 2025 $2,158
Food & beverage: $2,059Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $536 |
| Ardelyx, Inc. | 11 | $357 |
| Janssen Biotech, Inc. | 9 | $354 |
| QOL Medical, LLC | 8 | $210 |
| Intercept Pharmaceuticals, Inc. | 5 | $126 |
| Madrigal Pharmaceuticals | 5 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| NeurAxis, Inc. | 1 | $55 |
Products named: IBSRELA, TREMFYA, SKYRIZI, Sucraid, OCALIVA, REZDIFFRA, RINVOQ, CREON.
Industry payments across SC — which companies pay providers there.
